A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)

PHASE2TerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 18, 2010

Primary Completion Date

November 24, 2010

Study Completion Date

November 24, 2010

Conditions
Immune Thrombocytopenia (ITP)
Interventions
DRUG

Placebo

Tablet

DRUG

Lusutrombopag

Tablet

Trial Locations (19)

10021

Investigator, New York

10029

Investigator, New York

20007

Investigator, Washington D.C.

20817

Investigator, Bethesda

30274

Investigator, Riverdale

30341

Investigator, Atlanta

32207

Investigator, Jacksonville

33426

Investigator, Boynton Beach

44106

Investigator, Cleveland

64131

Investigator, Kansas City

65109

Investigator, Jefferson City

70006

Investigator, Metairie

78229

Investigator, San Antonio

84132

Investigator, Salt Lake City

90272

Investigator, Los Angeles

92801

Investigator, Anaheim

98109

Investigator, Seattle

02114

Investigator, Boston

08903

Investigator, New Brunswick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shionogi

INDUSTRY